Earnings Call Summary | HeartBeam(BEAT.US) Q1 2024 Earnings Conference
Earnings Call Summary | HeartBeam(BEAT.US) Q1 2024 Earnings Conference
The following is a summary of the HeartBeam, Inc. (BEAT) Q1 2024 Earnings Call Transcript:
以下是HeartBeam, Inc.（BEAT）2024年第一季度業績電話會議記錄摘要：
Financial Performance:
財務業績：
HeartBeam's Q1 2024 general and administrative expenses decreased slightly to $2.4 million from $2.5 million in Q1 2023.
Research and development expenses rose significantly to $2.4 million from $1.7 million in Q1 2023.
The company experienced an increased net loss of $4.6 million in Q1 2024, from a net loss of $4.1 million in Q1 2023.
There was a drop in cash and cash equivalents to $12.6 million from $16.2 million.
Operational activities used net cash of $3.5 million in the first three months of 2024.
HeartBeam的2024年第一季度一般和管理費用從2023年第一季度的250萬美元略有下降至240萬美元。
研發費用從2023年第一季度的170萬美元大幅上升至240萬美元。
該公司在2024年第一季度的淨虧損從2023年第一季度的410萬美元淨虧損增加了460萬美元。
現金及現金等價物從1,620萬美元下降至1,260萬美元。
2024年前三個月，業務活動使用了350萬美元的淨現金。
Business Progress:
業務進展：
HeartBeam is actively progressing towards obtaining FDA clearance for its innovative AIMIGo system, anticipated by Q2 2024.
The company is developing the AIMIGo 3D VECG system, which is also under FDA review.
A significant focus of HeartBeam's strategy is the development of deep learning algorithms using 3D ECG signals.
It has gained recognition from the European Heart Rhythm Association.
The company is also refining its go-to-market strategy and sees a large potential market opportunity in the U.S., estimated at about $14 billion.
HeartBeam正在積極爭取其創新的AimiGO系統獲得美國食品藥品管理局的批准，該系統預計將在2024年第二季度獲得美國食品藥品管理局的批准。
該公司正在開發AimiGo 3D VECG系統，該系統也正在接受美國食品藥品管理局的審查。
HeartBeam戰略的一個重要重點是使用三維心電信號開發深度學習算法。
它獲得了歐洲心律協會的認可。
該公司還在完善其市場進入戰略，並認爲美國將面臨巨大的潛在市場機會，估計約爲140億美元。
More details: HeartBeam IR
更多詳情： HeartBeam 紅外
Tips: For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.
提示：欲了解更多詳情，請訪問投資者關係網站。本文僅供投資者參考，不構成任何投資建議。
譯文內容由第三人軟體翻譯。